Home › Interstitial Lung Diseases › North Carolina
Interstitial Lung Diseases clinical trials in North Carolina
18 studies for Interstitial Lung Diseases are looking for participants at sites in North Carolina.
Cities in North Carolina
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
- Coastal Carolina Health Care, P.A. Pulmonary and Sleep Medicine, New Bern
- Southeastern Research Center-Winston-Salem-61365, Winston-Salem
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT07540988Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- USA011, Durham
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT07179380LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- CTR South Cary, Cary
- Onsite Clinical (Rowan Diagnostic), Salisbury
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 29, 2026 · NCT05798923A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
- GSK Investigational Site, Durham
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT06572384A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
- University of North Carolina at Chapel Hill, Chapel Hill
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Sep 4, 2026 · NCT06968845Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- Southeastern Research Center, Winston-Salem
Recruiting
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT06911632A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
- Clinical Research Site, Greensboro
RecruitingPhase 2
Ages 18 to 85 · All sexes · Updated Sep 2, 2026 · NCT07333183DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- University of North Carolina at Chapel Hill, Chapel Hill
- Duke University School of Medicine, Durham
- Pulmonix, LLC, Greensboro
- and 2 more
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 26, 2026 · NCT06388421Platform Clinical Study for Conquering Scleroderma
- Duke University Medical Center, Durham
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT06195072RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
- Duke University, Durham
RecruitingPhase 2/3
Ages 18 to 75 · All sexes · Updated Aug 17, 2026 · NCT06328777Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- UNC Chapel Hill, Chapel Hill
- Duke University, Durham
- Pulmonix LLC, Greensboro
- and 1 more
RecruitingObservational study
Ages 21 and older · All sexes · Updated Aug 12, 2026 · NCT01915511H01 in Adults With Interstitial Lung Disease (The SOLIS Study)
- NIEHS Clinical Research Unit (CRU), Research Triangle Park
RecruitingPhase 2
Ages 18 to 100 · All sexes · Updated Jul 28, 2026 · NCT06325696Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease
- Duke University Health System, Durham
RecruitingPhase 2
Ages 4 and older · All sexes · Updated Jul 22, 2026 · NCT04925375Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
- Duke University Medical Center, Durham
- PulmonIx LLC, Greensboro
- East Carolina University, Greenville
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jul 13, 2026 · NCT05943535Pulmonary Hypertension SOLAR
- Duke University Medical Center, Durham
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Feb 24, 2026 · NCT04778046129Xe MRI Cardiopulmonary
- Duke University Medical Center, Durham
RecruitingPhase 2Healthy volunteers welcome
Ages 18 and older · All sexes · Updated Feb 4, 2026 · NCT06038630Hyperpolarized 129Xe MRI for Imaging Pulmonary Function
- Duke University Medical Center, Durham
RecruitingPhase 2Healthy volunteers welcome
Ages 18 and older · All sexes · Updated Jan 16, 2026 · NCT01280994Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
- Southeastern Research Center, Winston-Salem
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Nov 12, 2025 · NCT05975983From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.